177 related articles for article (PubMed ID: 22945879)
1. Diverse models for the prediction of HIV integrase inhibitory activity of substituted quinolone carboxylic acids.
Gupta M; Madan AK
Arch Pharm (Weinheim); 2012 Dec; 345(12):989-1000. PubMed ID: 22945879
[TBL] [Abstract][Full Text] [Related]
2. Superaugmented eccentric distance sum connectivity indices: novel highly discriminating topological descriptors for QSAR/QSPR.
Gupta M; Gupta S; Dureja H; Madan AK
Chem Biol Drug Des; 2012 Jan; 79(1):38-52. PubMed ID: 22014074
[TBL] [Abstract][Full Text] [Related]
3. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
4. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
Cheng Z; Zhang Y; Fu W
Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
[TBL] [Abstract][Full Text] [Related]
5. Predicting biological activity: computational approach using novel distance based molecular descriptors.
Dutt R; Madan AK
Comput Biol Med; 2012 Oct; 42(10):1026-41. PubMed ID: 22964398
[TBL] [Abstract][Full Text] [Related]
6. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
7. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
Yu S; Wang P; Li Y; Liu Y; Zhao G
SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
[TBL] [Abstract][Full Text] [Related]
8. QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.
Gupta P; Sharma A; Garg P; Roy N
Curr Comput Aided Drug Des; 2013 Mar; 9(1):141-50. PubMed ID: 23286784
[TBL] [Abstract][Full Text] [Related]
9. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
Ravichandran V; Shalini S; Sundram K; Sokkalingam AD
Eur J Med Chem; 2010 Jul; 45(7):2791-7. PubMed ID: 20347187
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Yang LM; Zheng YT; Chen F
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):671-6. PubMed ID: 22468749
[TBL] [Abstract][Full Text] [Related]
11. Computational modeling methods for QSAR studies on HIV-1 integrase inhibitors (2005-2010).
Ko GM; Reddy AS; Garg R; Kumar S; Hadaegh AR
Curr Comput Aided Drug Des; 2012 Dec; 8(4):255-70. PubMed ID: 22242796
[TBL] [Abstract][Full Text] [Related]
12. Models for the prediction of melanocortin-4 receptor agonist activity of 4-substituted piperidin-4-ol.
Gupta M; Madan AK
Int J Comput Biol Drug Des; 2013; 6(4):294-317. PubMed ID: 24088265
[TBL] [Abstract][Full Text] [Related]
13. Simplified molecular input-line entry system and International Chemical Identifier in the QSAR analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Toropova AP; Toropov AA; Benfenati E; Gini G
Chem Biol Drug Des; 2011 May; 77(5):343-60. PubMed ID: 21352501
[TBL] [Abstract][Full Text] [Related]
14. Predicting anti-HIV activity of dimethylaminopyridin-2-ones: computational approach using topochemical descriptors.
Dureja H; Madan AK
Chem Biol Drug Des; 2009 Feb; 73(2):258-70. PubMed ID: 19207429
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
16. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
de Melo EB; Ferreira MM
Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
Dessalew N
Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
Gupta P; Garg P; Roy N
Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
[TBL] [Abstract][Full Text] [Related]
19. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
[TBL] [Abstract][Full Text] [Related]
20. Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.
Dayam R; Al-Mawsawi LQ; Zawahir Z; Witvrouw M; Debyser Z; Neamati N
J Med Chem; 2008 Mar; 51(5):1136-44. PubMed ID: 18281931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
